News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jasco Pharmaceuticals, LLC to Present its Preclinical PIM Inhibitor Program at the American Association for Cancer Research Annual Meeting


4/1/2011 10:44:02 AM

WOBURN, Mass.--(BUSINESS WIRE)--Jasco Pharmaceuticals, LLC announced that preclinical data on its PIM inhibitor program would be presented at the American Association for Cancer Research (AACR) Annual Meeting to be held on April 2-6, 2011 in Orlando, FL.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES